An early South African study on the Omicron coronavirus variant finds that people who received the Pfizer-BioNTech vaccine could still be vulnerable to breakthrough infection, though a third booster shot appears to offer greater protection. Early data has not shown Omicron causes more severe illness, and health officials have reaffirmed widespread vaccination is the best protection against COVID-19.